Analyst Ratings for Pelthos Therapeutics (PTHS)
PTHS Rating Summary
PTHS Price Target Summary
- Highest: $66.00 (Oppenheimer)
- Lowest: $48.00 (Piper Sandler)
- Average: $55.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$55.17 (+89.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/1/2026 | Cantor Fitzgerald | Olivia Brayer | New Coverage | Overweight (N/A) |
50.00 (N/A) |
21.01 (29.12) |
38.6% | Details |
| 2/27/2026 | Piper Sandler | David Amsellem | New Coverage | Overweight (N/A) |
48.00 (N/A) |
23.00 (29.12) |
26.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
